| Literature DB >> 35140516 |
Chengqiang Zheng1, Tianxiu Zhou2.
Abstract
PURPOSE: Fibromyalgia (FM) is a syndrome characterized by widespread pain, which caused huge economic and social burden. Acupuncture is often used to manage chronic pain. However, the efficacy of acupuncture in FM is still controversial. This study aimed to systematically review the effects of acupuncture on pain, fatigue, sleep quality, physical function, stiffness, well-being, and safety in FM.Entities:
Keywords: acupuncture; fibromyalgia; meta-analysis; pain; systematic review
Year: 2022 PMID: 35140516 PMCID: PMC8820460 DOI: 10.2147/JPR.S351320
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Flow chart for research selection strategy based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement.
Characteristics of Included Studies
| Source | Setting | Sample Size | Intervention | Treatment Duration | Outcome Measures | Time Point | Adverse Effects |
|---|---|---|---|---|---|---|---|
| Deluze et al, 1992 | Switzerland | 28/27 | AG: EA (individually adapted); | 6 sessions, 3 weeks | Pain: VAS (1–100 mm) | Before and after treatment | Increase in symptoms, unpleasantness of needle insertion, ankle oedema, and hospitalized for unrelated condition |
| Sprott, 1998 | Germany | 10/10/10 | AG: MA (individually adapted); | 6 sessions, 2 sessions/week | Pain: VAS | Before and after treatment, 2 months after the treatment | NR |
| Assefi et al, 2005 | USA | 25/25/24/25 | AG: MA (standardized) | 12 weeks, 2 sessions/week (24 sessions) | Pain: VAS (10 is worst pain); fatigue: VAS (10 is worst); sleep quality: VAS (10 is best); physical function: SF-36; well-being: VAS (10 is best) | Baseline, 1, 4, 8, and 12 weeks of treatment, and 3 and 6 months after treatment | Bruising, nausea, faint, discomfort. |
| Harris et al, 2005 | USA | 29/30/28/27 | AG: MA (individually adapted) | 18 sessions | Pain: VAS (0–100) | 0, 3, 4, 8, 9, 13, 15 weeks | NR |
| Martin et al, 2006 | USA | 25/24 | AG: EA (standardized) | 6 sessions for 2–3 weeks | Pain: FIQ; fatigue: FIQ; sleep: FIQ; physical function: FIQ; stiffness: FIQ; well-being: FIQ | Before and after treatment, at 1 month and 7 months after treatment | AG: mild vasovagal symptoms, mild bruising and soreness |
| Harris et al, 2009 | USA | 10/10 | AG: MA (individually adapted) | 9 treatments, 4 weeks | Pain: SF-MPQ | 0, 4 weeks | NR |
| Harte et al, 2013 | USA | 22/28 | AG: MA (standardized) | 9 sessions for 4 weeks | Pain: SF-MPQ | Before and after treatment | NR |
| Stival et al, 2014 | Brasil | 21/15 | AG: MA (standardized) | 1 session for 20 minutes | Pain: VAS | Before and after the proposed procedure | NR |
| Vas et al, 2016 | Spain | 80/82 | AG: MA (individually adapted) | 1 session/week, 9 sessions | Pain: VAS (0–100 mm); fatigue, sleep, stiffness, and well-being: FIQ; physical function: SF-12; | Baseline and at 10 weeks, 6 months, and 12 months after the 1st session | AG: post-acupuncture pain, post-acupuncture bruising, and post-acupuncture vagal symptoms |
| Uğurlu et al, 2017 | Turkey | 25/25 | AG: MA (standardized) | 12 sessions | Pain: VAS (0–10); fatigue: FSS; physical function: SF-36; well-being: FIQ | Baseline, 1 month and 2 months after the 1st session | NO |
| Zucker et al, 2017 | USA | 59/55 | AG: MA (standardized) | 18 sessions | Pain: VAS (0–100) | Before and after treatment | NR |
| Karatay et al, 2018 | Turkey | 24/25/23 | AG: MA (standardized) | 8 sessions | Pain: VAS; sleep: NHP; physical function: NHP; well-being: FIQ | Baseline, after the last treatment, | NO |
| Mawla al., 2021 | USA | 35/37 | AG: EA (standardized) | 8 weeks, 2 sessions/week | Pain: BPI | Before and after treatment | NR |
Abbreviations: NA, not availability; NR, not reported; AG, acupuncture group; CG, control group; EA, electroacupuncture; MA, manual group; VAS, visual analogue scale; SF-36, short form-36; SF-12, short form-12; FIQ, fibromyalgia impact questionnaire; SF-MPQ, short form of McGill pain questionnaire; FSS, fatigue severity scale; BPI, brief pain inventory.
Figure 2Bias risk assessment for included studies.
Effect Sizes of Acupuncture Group Compared with Control Group on Selected Outcome Variables
| Outcome Title | Number of Studies | Number of Patients | Effect Size SMD (95% CI) | Test for Overall Effect | Heterogeneity I2 |
|---|---|---|---|---|---|
| Post-treatment | |||||
| 1.Pain | 12 | 715 | −0.42 [−0.66, −0.17] | 58% | |
| 2.Fatigue | 4 | 251 | −0.03 [−0.42, 0.35] | 0.87 | 54% |
| 3.Sleep | 2 | 151 | −0.38 [−0.78, 0.02] | 0.06 | 0% |
| 4.Physical function | 3 | 268 | 0.14 [−0.51, 0.79] | 0.67 | 83% |
| 5.Stiffness | 2 | 104 | −0.38 [−0.77, 0.01] | 0.06 | 27% |
| 6.Well-being | 4 | 357 | −0.86 [−1.49, −0.24] | 85% | |
| Latest follow-up | |||||
| 1.Pain | 4 | 356 | −0.40 [−0.77, −0.03] | 60% | |
| 2.Fatigue | 2 | 145 | 0.04 [−0.52, 0.59] | 0.90 | 58% |
| 3.Sleep | 2 | 98 | −0.64 [−1.77, 0.49] | 0.27 | 86% |
| 4.Physical function | 2 | 98 | −0.25 [−0.91, 0.41] | 0.46 | 63% |
| 5.Well-being | 3 | 307 | −0.58 [−0.82, −0.35] | 0% |
Note: Bold text indicates that the P-value is less than 0.05.
Abbreviations: SMD, standardized mean difference; CI, confidence interval.
Figure 3Forest plots of the analgesic effect of acupuncture in the post-treatment. (A) Subgroup analysis: manual acupuncture vs electroacupuncture. (B) Subgroup analysis: individual adapted acupuncture vs standardized acupuncture. (C) Subgroup analysis: less than 10 sessions vs more than 10 sessions.
Figure 4The forest plot of adverse events.
Figure 5Publication bias funnel plots of standard errors and effect sizes of the included studies.